How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Dec 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Odyssey buys BenevolentAI in Europe's top SPAC deal

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

Nov 29
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

How AI Is Aiming at the Bad Math of Drug Development

Oct 6
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

UBS clients raise $650 mln for biggest yet biotech impact fund

Dec 5
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analyst shares the impact of ML applications in LS

Dec 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Tech analyst reports expansion for European tech

Dec 28
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Industry insiders recount top medtech wins of 2021

Oct 6
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

UBS clients raise $650 mln for biggest yet biotech impact fund

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus